Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits
At Morpheus , we are committed to staying at the forefront of medical advancements in wellness for our patients.
The Portrait Marketplace has more than 2,000 medical products to pick from
Phase 2 trial (NEJM 2023) reported 24.2% mean weight loss at 48 weeks with 12 mg/week retatrutide, with gastrointestinal adverse events rising sharply at the 8 mg and 12 mg doses
Klow Blend has not been evaluated or approved by the FDA
It measures the levels of 114 contaminants, including several that are uncommon in public, treated water supplies, including coliform bacteria, nitrates and nitrites, and arsenic